AI-Native Scoping Reviews & Evidence Mapping

Medical podcasts are no longer just convenient audio extras — this evidence map shows where they actually improve knowledge, confidence, clinical skills, CME behavior, and patient-facing communication, and where their impact remains limited. The full read separates strong educational signals from hype, including AI-generated podcasts, quality-transparency gaps, listener behavior, and the practical standards needed before podcasts can be trusted as serious medical-learning infrastructure.

Buttock augmentation safety is not defined by aesthetics alone: this evidence map shows that risk concentrates around where material is placed and what material is used, with subcutaneous image-guided fat grafting looking far safer than intramuscular injection or illicit permanent fillers. The full read separates low-complication fat-grafting and implant techniques from the dangerous edge cases — fat embolism, silicone embolism, septic shock, granulomatous hypercalcemia, sciatic nerve injury, and difficult filler migration — giving clinicians and patients a practical map of where buttock augmentation becomes unsafe.

Research automation is no longer a futuristic add-on — this review shows where it is already transforming science, from trial recruitment and evidence synthesis to laboratory workflows and multimodal data pipelines, often cutting manual work by more than 90% without sacrificing performance. Across 1,679 original studies, the paper maps not only where automation truly delivers speed, scale, and reproducibility, but also where human oversight remains the difference between safe acceleration and costly over-trust.

Mobile health clinics are not just outreach vans; they emerge as equity infrastructure that can bring screening, diagnosis, treatment initiation, and trust directly to populations fixed-site care often misses. The full evidence map shows where MHCs truly deliver value, where continuity breaks down after the first encounter, and which models are most likely to convert access into sustained care.

Digital twins are moving beyond engineering hype into practical decision systems for medicine, industry, infrastructure, and public health—linking real-world data to virtual models that can predict, optimize, and guide action. This full evidence map of 220 references and 1,347 original studies shows where digital twins already deliver measurable signals, where they remain experimental, and which domains are closest to real-world clinical or operational impact.

Transhumanism is no longer only a futuristic philosophy: this evidence map shows how wearables, biohacking, microchipping, XR, and human–machine prototypes are already reshaping identity, embodiment, and social acceptance. The full review separates empirical signals from speculative claims, showing where augmentation appears practical, emotionally driven, culturally normalized, or ethically contested.

This review shows that COVID-19 vaccination was generally linked to lower mortality, especially in older and high-risk groups, but that protection decreased over time and improved again after booster doses. Read the full paper to see where the evidence is strongest, which groups benefit most, and where important safety and interpretation questions remain.

Aspiration thrombectomy is not a universal “clot-removal solution”: this evidence map shows where it works best, where it fails to improve outcomes, and why stroke, STEMI, PE, DVT, and peripheral indications must be judged separately. The full read gives a clinically useful cross-territory synthesis of device choice, catheter strategy, thrombus biology, rescue techniques, safety signals, and indication-specific evidence gaps.

EPDs are not simply “filters”: across TAVR, carotid stenting, SVG PCI, renal, peripheral, and structural interventions, they reliably capture or deflect embolic material, but clinical benefit depends sharply on anatomy, procedure, device design, and endpoint choice. This evidence map shows where protection appears meaningful, where routine use remains unproven, and why the future of EPDs is likely selective, anatomy-informed deployment rather than universal application.